Dhingra Ankur's Form 4 filing
Summit Therapeutics Inc. (SMMT) · filed Dec 13, 2023
- Accession no.
- 0001599298-23-000101
- Filed
- Dec 13, 2023
- Trade date
- Dec 13, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $44.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dhingra AnkurCIK 0001849682 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | Common Stock | PPurchaseAcquired | +700 | $2.15 | +$1,505 | 235,258 | Indirect | |
| Dec 13, 2023 | Common Stock | PPurchaseAcquired | +19,700 | $2.17 | +$42,749 | 254,958 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.